Hrt Financial »

Adaptimmune Therapeutics shares owned by Hrt Financial

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Hrt Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $47k 60k 0.78
2023-03-31 $19k 18k 1.05
2022-06-30 $35k 21k 1.66
2021-06-30 $181k 43k 4.25
2019-12-31 $53k 44k 1.20